Patents by Inventor Yngve Elof Hansson

Yngve Elof Hansson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Monoclonal antibody
    Patent number: 6716594
    Abstract: The invention relates to monoclonal antibody capable of specific binding to the molecular weight of 20 kDa variant of human growth hormone. This monoclonal antibody has no substantial binding to hGH of molecular weight 22 kDa. The invention also relates to the use of this monoclonal antibody for measurement of hGH 20K, especially in body fluids. The antibodies can be used for detection and quantification of hGH 20K, especially in serum.
    Type: Grant
    Filed: June 16, 1999
    Date of Patent: April 6, 2004
    Assignees: Pharmacia Spain SA, Consejo Superior de Investigaciones Scientificas
    Inventors: Yngve Elof Hansson, Leonor Kremer Baron, Carlos Martínez Alonso, José Mario Mellado Garcia, José Miguel Rodriguez Frade
  • Monoclonal antibody
    Patent number: 5945296
    Abstract: The invention relates to monoclonal antibody capable of specific binding to the molecular weight of 20 kDa variant of human growth hormone. This monoclonal antibody has no substantial binding to hGH of molecular weight 22 kDa. The invention also relates to the use of this monoclonal antibody for measurement of hGH 20K, especially in body fluids. The antibodies can be used for detection and quantification of hGH 20K, especially in serum.
    Type: Grant
    Filed: March 28, 1997
    Date of Patent: August 31, 1999
    Assignees: Pharmacia & Upjohn AB, Consejo Superior de Investigaciones
    Inventors: Yngve Elof Hansson, Leonor Kremer Baron, Carlos Martinez Alonso, Jose Mario Mellado Garcia, Jose Miguel Rodriguez Frade